Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Contour Health vs Wisp

Contour Health
Graded #177

Higher grade

vs+2.3999999999999915
Wisp
Graded #243

Lower grade

The verdict

Contour Health takes it — 66.8/100 to 64.4/100.

Contour Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Contour Health (Desert Contour LLC) is a Utah-based telehealth provider offering compounded semaglutide and tirzepatide through a named 503A pharmacy partner, Strive Pharmacy.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueContour Health +15
65
50
Dose & formulationWisp +12
64
76
Clinical oversightContour Health +3
85
82
Labs & monitoringEven
53
53
FulfillmentContour Health +4
70
66
Contract termsEven
55
55
Contour Health · left barWisp · right bar

The numbers

MetricContour HealthWisp
WeighScore66.8/10064.4/100
GradeCC
Scorecard rank#177#243
Semaglutide$160/mo (starting dose, compounded)$225/mo (compounded oral)
Tirzepatide$300/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Contour Health

Graded #177 · C

Strengths

  • Free medical consultation — no charge to talk with a provider before starting
  • Pay-per-vial pricing with no long-term subscription commitment required to participate
  • Names its compounding pharmacy partner (Strive Pharmacy, 503A accredited) — a real transparency signal
  • LegitScript badge links to a genuine, working LegitScript verification checker for the domain
  • Board-certified Medical Director and named nurse-practitioner care team, not anonymous providers

Where it loses points

  • State availability list is not published — Terms of Service only says "certain states"
  • All product purchases are non-refundable per Terms of Service
  • Compounded injectable only — no oral option, no brand-name Wegovy/Zepbound/Ozempic/Mounjaro
  • Terms of Service also describe an optional subscription tier with a 3-month minimum, despite marketing emphasizing "no subscriptions"
  • No insurance, Medicare, or Medicaid accepted — cash-pay or HSA/FSA only
Wisp

Graded #243 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
  • The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
  • Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard